These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15677439)

  • 1. Effects of chronic stress on methamphetamine-induced dopamine depletions in the striatum.
    Matuszewich L; Yamamoto BK
    Ann N Y Acad Sci; 2004 Dec; 1032():312-4. PubMed ID: 15677439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic stress enhances methamphetamine-induced extracellular glutamate and excitotoxicity in the rat striatum.
    Tata DA; Yamamoto BK
    Synapse; 2008 May; 62(5):325-36. PubMed ID: 18288648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic stress augments the long-term and acute effects of methamphetamine.
    Matuszewich L; Yamamoto BK
    Neuroscience; 2004; 124(3):637-46. PubMed ID: 14980734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotoxic effects of chronic restraint stress in the striatum of methamphetamine-exposed rats.
    Quinton MS; Yamamoto BK
    Psychopharmacology (Berl); 2007 Aug; 193(3):341-50. PubMed ID: 17458543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature.
    Johnson BN; Yamamoto BK
    J Pharmacol Exp Ther; 2010 Oct; 335(1):180-9. PubMed ID: 20634423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward development of an in vitro model of methamphetamine-induced dopamine nerve terminal toxicity.
    Kim S; Westphalen R; Callahan B; Hatzidimitriou G; Yuan J; Ricaurte GA
    J Pharmacol Exp Ther; 2000 May; 293(2):625-33. PubMed ID: 10773037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of methamphetamine-induced toxicity in the rat striatum by unpredictable stress: contribution of enhanced hyperthermia.
    Tata DA; Raudensky J; Yamamoto BK
    Eur J Neurosci; 2007 Aug; 26(3):739-48. PubMed ID: 17686046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrates of energy metabolism attenuate methamphetamine-induced neurotoxicity in striatum.
    Stephans SE; Whittingham TS; Douglas AJ; Lust WD; Yamamoto BK
    J Neurochem; 1998 Aug; 71(2):613-21. PubMed ID: 9681451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine.
    Chapman DE; Hanson GR; Kesner RP; Keefe KA
    J Pharmacol Exp Ther; 2001 Feb; 296(2):520-7. PubMed ID: 11160639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of Na(+)/H(+) and Na(+)/Ca(2+) exchange potentiate methamphetamine-induced dopamine neurotoxicity: possible role of ionic dysregulation in methamphetamine neurotoxicity.
    Callahan BT; Cord BJ; Yuan J; McCann UD; Ricaurte GA
    J Neurochem; 2001 Jun; 77(5):1348-62. PubMed ID: 11389186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxic regimen of methamphetamine produces evidence of behavioral sensitization in the rat.
    Wallace TL; Gudelsky GA; Vorhees CV
    Synapse; 2001 Jan; 39(1):1-7. PubMed ID: 11071703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase activity contributes to the monoaminergic damage caused by serial exposure to stress and methamphetamine.
    Northrop NA; Yamamoto BK
    Neuropharmacology; 2013 Sep; 72():96-105. PubMed ID: 23643743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine.
    Itzhak Y; Martin JL; Ali SF
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1177-83. PubMed ID: 12452543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux.
    Stephans SE; Yamamoto BK
    Synapse; 1994 Jul; 17(3):203-9. PubMed ID: 7974204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.
    LaVoie MJ; Hastings TG
    J Neurosci; 1999 Feb; 19(4):1484-91. PubMed ID: 9952424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and activity of nitric oxide synthase isoforms in methamphetamine-induced striatal dopamine toxicity.
    Friend DM; Son JH; Keefe KA; Fricks-Gleason AN
    J Pharmacol Exp Ther; 2013 Feb; 344(2):511-21. PubMed ID: 23230214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic unpredictable stress augments +3,4-methylenedioxymethamphetamine-induced monoamine depletions: the role of corticosterone.
    Johnson BN; Yamamoto BK
    Neuroscience; 2009 Apr; 159(4):1233-43. PubMed ID: 19409219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice.
    Zhu JP; Xu W; Angulo JA
    Brain Res; 2005 Jul; 1049(2):171-81. PubMed ID: 16043139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of neurotoxic doses of methamphetamine on methamphetamine-conditioned place preference in rats.
    Gehrke BJ; Harrod SB; Cass WA; Bardo MT
    Psychopharmacology (Berl); 2003 Mar; 166(3):249-57. PubMed ID: 12589519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine administration reduces hippocampal vesicular monoamine transporter-2 uptake.
    Rau KS; Birdsall E; Volz TJ; Riordan JA; Baucum AJ; Adair BP; Bitter R; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2006 Aug; 318(2):676-82. PubMed ID: 16687477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.